National Adult Vaccination Program - Podcasts, Webinars, Fact Sheets, Decision Tools and Infographics

Article Index

Podcasts, Webinars, Fact Sheets, Decision Tools and Infographics


Understanding the Vaccine Development Process

The process of bringing a vaccine to market takes extensive research and safety monitoring. Dr. Gordon Douglas explains the steps from preclinical studies to vaccine licensure, and discusses his own experience developing vaccines at a major manufacturer for 30 years. He also shares lessons learned from clinical trials during the COVID-19 pandemic, including the importance of participant diversity. 

GuestR. Gordon Douglas, Jr, MD, Professor Emeritus, Weill Cornell Medical College

Host: Jo-Ana Chase, PhD, APRN-BC, Associate Professor, Sinclair School of Nursing, University of Missouri Health

This podcast episode is supported by Seqirus. Content was developed by The Gerontological Society of America (GSA).

Applying Risk Communication Models to Immunization Discussions

Communicating the risks and benefits of immunization can be challenging, as the language of science may not always be well understood by the public. Dr. Aaron Scherer shares his research on risk communication and infectious disease, what we can learn from outbreak communication with older adults, and his thoughts on future opportunities in the field.

GuestAaron Scherer, MA, PhD, Assistant Professor of Internal Medicine - General Internal Medicine, University of Iowa

Host: Cheryl Ann Monturo, PhD, MBE, ACNP-BC, Senior Nurse Research Scientist Chester County Hospital/Penn Medicine; Professor of Nursing West Chester University

This podcast episode is supported by Seqirus. Content was developed by The Gerontological Society of America (GSA).

Integrating Immunization in Long-Term Care

A routine immunization program in long-term care facilities can protect residents who are most at risk of poor outcomes if they contract a vaccine-preventable disease, however systemic challenges contribute to stagnant vaccination rates among residents and low vaccination rates among staff. In this episode, Dr. Barbara Resnick discusses her work in improving immunization rates in long-term care, using behavior motivation techniques to encourage staff and residents to get vaccinated, and what she sees as opportunities for future researchers and practitioners.

Guest: Barbara Resnick, PhD, RN, CRNP, FAAN, FAANP, Sonya Ziporkin Gershowitz Chair in Gerontology, University of Maryland School of Nursing

Host: Justine Sefcik, PhD, RN, Assistant Professor, Drexel University College of Nursing and Health Professions; Co-convener, GSA Interest Group on Nursing

This podcast episode is supported by Seqirus. Content was developed by The Gerontological Society of America (GSA).

Fact Sheets

GSA, in collaboration with Gerontological Advanced Practice Nurses Association (GAPNA) and AMDA, has launched a new project focused on improving education and awareness of enhanced influenza vaccine products.


Elevating Understanding of RSV in Older Adults
A GSA Webinar
August 31, 2020

Respiratory syncytial virus, or RSV, causes 177,000 hospitalizations and 14,000 deaths in older adults each year. Those over 65, adults with chronic heart or lung disease, and adults with weakened immune systems are particularly at risk. Yet RSV remains underdiagnosed.

In this one-hour webinar, experts will share what is known about the prevalence, incidence, and impact of RSV in older adults. Participants will understand the symptoms and differential diagnoses for the disease and identify the reasons for underdiagnoses in older adults. Recent coding changes to improve diagnosis will be discussed, along with specific tips for communication techniques for providers at each phase of interaction with older adults who have RSV.


  • Robin Jump, MD, PhD – Case Western Reserve University, Louis Stokes Cleveland VA Medical Center
  • Lindsay Kim, MD, MPH – Centers for Disease Control and Prevention
  • Helen “Keipp” Talbot, MD, MPH – Vanderbilt University Medical Center

This webinar is supported by Johnson and Johnson Health Systems, Inc. Content is developed by GSA. Contact This email address is being protected from spambots. You need JavaScript enabled to view it. for more information.

Understanding the Value of Enhanced Influenza Vaccine Products in Long-Term Care Settings
A GSA Webinar
September 17, 2020

There are many benefits to preventing flu transmission in long-term care settings yet only about two-thirds of nursing home residents receive annual influenza vaccinations—one of the best known preventive strategies. The COVID-19 pandemic has further amplified the need for effective infection control in these settings. Compared with standard-dose influenza vaccines, enhanced influenza vaccines are not only more effective in preventing disease in older adults, they also provide a higher return on investment. This webinar is designed to help nursing home administrators, infection control teams, and other long-term care staff to (1) understand the benefits of using enhanced influenza vaccine products in residents and (2) learn practical tips that can help leadership and staff consistently apply immunization practices.

Presented by:

  • R. Gordon Douglas, MD, Chair, National Adult Vaccination Program Workgroup; Professor Emeritus, Weill Cornell Medical College (Moderator)
  • David H. Canaday, MD, Professor of Medicine, Case Western Reserve University; Associate Director, Geriatric, Research, Education, and Clinical Center (GRECC), Louis Stokes Cleveland VA Medical Center; Division of Infectious Diseases and HIV Medicine, University Hospitals Cleveland Medical Center
  • Sherry A. Greenberg, PhD, RN, GNP-BC, FGSA, FAANP, FAAN, Associate Professor, Seton Hall University College of Nursing; President-Elect, Gerontological Advanced Practice Nurses Association
  • Barbara Resnick, PhD, RN, CRNP, FAAN, FAANP, Professor, University of Maryland School of Nursing; Co-Director, Biology and Behavior Across the Lifespan Organized Research Center; Sonya Ziporkin Gershowitz Chair in Gerontology

This program was jointly developed by GSA, the Gerontological Advanced Practice Nurses Association, and AMDA – The Society for Post-Acute and Long-Term Care Medicine, with support from Sanofi.


GSA COVID Combined2

Immunization rates of staff and residents in long-term care facilities are low, even though strategies to improve rates are well known. Leaders gathered at a meeting hosted by GSA in May 2018 to discuss the issue and prioritize actions to improve rates. A shareable PDF is also available.


Immune function wanes in all adults—whether healthy or sick—as they age into their fifth decade and beyond. Their bodies become less adept at recognizing and stopping pathogens, and the ability to develop and maintain immunity declines. Also known as immunosenescence, age-related decline in immunity significantly contributes to the susceptibility of older adults to serious conditions, including influenza, pneumonia, and shingles.

The following infographics explain these concepts in easy-to-share formats. See the link below each infographic for a PDF copy. 

Infographic part1 final

 Click here for the PDF copy of Part 1: Immunity As We Age.

Infographic part2 final

 Click here for the PDF copy of Part 2: Shingles - A Case Study in Immunity and Vaccines.

Share This Page!

Print Page